Participants 68 99 7
in anemic patients with cancer.
Participants 216 255 7
patients with cancer-associated anemia.
Participants 277 331 4
Eligible patients were randomly assigned at enrollment
Participants 556 604 9
Three hundred sixty-five patients were enrolled.
Participants 605 707 3
One hundred eighty-three patients were assigned to the 40K arm, and 182 were assigned to the 120K arm.
